Phillip Frost - May 13, 2024 Form 4 Insider Report for Fluent, Inc. (FLNT)

Role
10%+ Owner
Signature
/s/ Phillip Frost, M.D., Individually
Stock symbol
FLNT
Transactions as of
May 13, 2024
Transactions value $
$2,000,002
Form type
4
Date filed
5/15/2024, 09:30 PM
Previous filing
Mar 18, 2024
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FLNT Common Stock 3.14M May 13, 2024 Held by Frost Gamma Investments Trust F1, F4
holding FLNT Common Stock 8.33K May 13, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLNT Pre-Funded Warrant Award $2M +591K $3.38 591K May 13, 2024 Common Stock 591K $0.00 Held by Frost Gamma Investments Trust F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 11, 2024, the Issuer effected a 6-for-1 reverse stock split. The holding reported here reflects such reverse stock split.
F2 The Pre-Funded Warrants will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. The binding agreement for the transaction was entered into on May 13, 2024.
F3 The Pre-Funded Warrants will terminate when exercised in full.
F4 These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.